Clinical trial Recruiting at 1 site Interventional Ages 18 and up

A program to support head and neck cancer survivors and their caregivers

Official title: A Randomized Controlled Trial to Evaluate the Survivorship Needs Assessment Planning (SNAP) Tool for Head and Neck Cancer Survivor-Caregiver Dyads

Run by Medical University of South Carolina · NCT05811936 · Data updated 2026-11-12

This study is testing a new support program for head and neck cancer survivors and their caregivers to see if it helps them manage symptoms and reduces stress compared to regular care.

More Head and Neck Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment352 (estimated)
SponsorMedical University of South Carolina
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Charleston, South Carolina)
StatusRecruiting
StartedAugust 23, 2023
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJune 11, 2026
Trial IDNCT05811936 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with stage I-IV non-metastatic head and neck cancer currently undergoing radiation treatment, along with a nominated caregiver.

Probably not a fit

Patients who are cognitively impaired or do not understand English may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention involves head and neck cancer survivors and their caregivers participating in a randomized trial to assess the effectiveness of the Survivorship Needs Assessment Planning (SNAP) tool compared to usual care. The SNAP tool includes two sessions that provide a needs assessment, tailored care plan, and a supportive mobile app to enhance care after radiation treatment. The study aims to evaluate the impact of SNAP on symptom severity for patients and caregiver burden, as well as secondary outcomes like psychological distress and healthcare utilization. Participants will complete surveys at baseline, 6 months, and 9 months post-randomization to measure various health outcomes.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life for head and neck cancer survivors and reduce the burden on their caregivers.

How similar studies have gone: Other studies have shown promise in using tailored interventions for cancer survivorship, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patient Inclusion Criteria:

1. Age \>18
2. Stage I-IV non-metastatic HNC (i.e., lip/oral cavity, nasopharynx, salivary gland, oropharynx, hypopharynx, paranasal sinus, larynx and cutaneous cancers)
3. Currently receiving radiation treatment (with/without surgery and/or concurrent chemotherapy) with curative intent
4. Able to nominate caregiver, the primary support person, also interested in participating

Caregiver Inclusion Criteria:

1. Age \>18
2. Provide care for a loved one with stage I-IV HNC
3. Agrees to participate after being nominated

Patient Exclusion Criteria:

1. Patients who do not read/understand English
2. Patients who are cognitively impaired and cannot complete interviews as judged by the referring health care provider
3. Patients concurrently diagnosed with and/or receiving treatment for a second "significant" primary cancer, except the following:

   * Excised and cured non-melanoma skin cancer
   * Carcinoma in situ of breast or cervix
   * Superficial bladder cancer
   * Stage 1 differentiated thyroid cancer that is resected or observed
   * pT1a/pT1b prostate cancer comprising \<5% of resected tissue with normal prostate specific antigen (PSA) since resection
   * cT1a/cT1b prostate cancer treated with brachytherapy

Caregiver Exclusion Criteria:

1. Inability to read or understand English
2. Cognitively impaired and cannot complete interviews, as judged by the referring health care provider

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Katherine R Sterba, PhD, MPH — Medical University of South Carolina
  • Study coordinator: Katherine R Sterba, PhD, MPH
  • Email: sterba@musc.edu
  • Phone: 8438762419

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.